SILVER SPRING, Md. — Lupin is adding to its topical generics portfolio. The Food and Drug Administration has approved Lupin’s generic of Galderma Laboratories’ Clobex (clobetasol propionate, 0.05%) lotion, the company announced Tuesday.
The product is indicated to relieve various corticosteroid-responsive dermatoses in patients ages 18 years and older. For the 12 months ended June 2017, the drug had U.S. sales of $14.3 million, according to QuinitlesIMS data.